1. Reduce or eliminate potentially harmful dose preparation errors such
as using the wrong drug, the wrong diluents, or the wrong amount while
making a patient dose.
2. Reduce or eliminate hazardous exposure to cytotoxic drugs for I.V.
technicians, nurses, and pharmacists, and cross-contamination risks
for patients.
3. Improve safety and productivity for pharmacists by enabling them to
perform required dose inspections remotely, eliminating the need to
enter the I.V. room.
IntelliFillchemo's ToxiSafe Protection System meets all three challenges:
1. Being certain that every dose is correct -- one dose at a time:
The precision of the IntelliFillchemo robotics platform far exceeds the
capabilities of human operators, and eliminates the need for technicians to
manually handle drugs and sharps. IntelliFillchemo ensures that doses of
virtually any format -- bags, a wide range of syringes using needle or
needleless systems -- are made correctly:
-- IntelliFillchemo automatically calculates dilutions and dose amounts --
reducing the chances of calculation errors. IntelliFillchemo's robotic
platform performs all dilutions.
-- Robotics + Barcoding + RFID combine to reduce/eliminate opportunities
for using wrong drugs or wrong diluents or wrong amounts. Every drug and
diluent used to make every dose is verified by barcode scanning to be the
correct ingredient for each patient.
-- Every component of every dose is measured with robotic accuracy and
verified by weight.
2. Preventing exposure to cytotoxic drugs from preparation to
administration:
Protecting operators, caregivers, and patients from exposure requires more
than automation -- it requires a new approach to the system enclosure and
to how drugs, doses, and waste are managed.
IntelliFillchemo is the first and only solution that provides total
containment of cytotoxics from the beginning of dose preparation through
delivery to the patient bedside.
-- IntelliFillchemo's true laminar airflow enclosure uses glove ports to
enable safe operator access and does not require the operator to wear
multiple layers of gloves and gowns. Even small amounts of cytotoxic drugs
are hazardous -- and work areas for preparing chemotherapy doses must be
regularly cleaned with specialized decontaminating agents. The entire
IntelliFillchemo system can be sprayed with decontaminant without opening
the enclosure, as compared to other dose preparation systems that must be
opened to decontaminate. IntelliFillchemo's enclosure also can be used for
manual cytotoxic dose preparation as needed -- eliminating the need for
another airflow hood for manual dose prep. The system is smaller than
competitive designs and easier for hospitals to facilitize because it uses
less power and generates less heat.
-- Technicians never need to directly handle doses or wastes. All
finished doses, waste, and unused products are individually bagged and
sealed before leaving the system. Some other systems simply eject doses and
waste -- which can expose operators, staff, and patients to cytotoxic
contamination. IntelliFillchemo's sealed dose bags need not be unsealed
until doses are administered, dramatically reducing contamination risks
throughout the hospital.
3. Enabling pharmacists to perform more thorough inspections without
entering the I.V. room
There's little visibility of manual preparation in I.V. rooms today -- and
pharmacists must enter the I.V. room to inspect dose preparation steps,
requiring time to put on gowns and gloves. IntelliFillchemo brings new
visibility to the current work in the I.V. room and enables pharmacists to
perform inspections remotely.
All dose preparation steps are recorded, barcodes are verified and
captured, and each step is completely auditable. A digital photographic
audit trail documents all key dose preparation steps.
IntelliFillchemo's impact on safety:
According to Dennis Tribble, "Our customers trust us to know the I.V. room.
They expect that we will translate that knowledge into safer and better
products. IntelliFillchemo and its ToxiSafe Protection System is the only
fully contained system. It is therefore the safest way to automate
cytotoxic dose preparation."
IntelliFillchemo's impact on the bottom line:
Beyond simply breaking new ground in safety, IntelliFillchemo also breaks
new ground in value. The cost of making a single chemotherapy dose can be
as high as $65 -- and a mid-sized hospital may make thousands of these
doses each year. Through a combination of productivity improvements,
reductions in drug waste, and the savings achieved by reducing the need for
massive amounts of disposable protective clothing and other expensive
containment approaches, the system can dramatically reduce the cost of
preparing each dose.
According to Steve Thomas, "IntelliFillchemo is the safest product and the
lowest-priced product, making it the hands-down winner. Our company has 10
years' experience, and this is our second breakthrough announcement in just
15 weeks. Our commitment to innovation in the I.V. room is attracting many
new customers and extending our leadership in I.V. room automation."
IntelliFillchemo will be on display in just 10 weeks at the ASHP Summer
2008 Meeting (June 8-11 in Seattle, WA). ForHealth Technologies will
showcase its full line of innovative, leading products in booth 605. Steve
Thomas added, "IntelliFlowRx was the hottest new product at the December
2007 ASHP Mid-Year Clinical Meeting in Las Vegas, and IntelliFillchemo will
be the hottest product in Seattle." Additional information on
IntelliFillchemo will be available at the meeting.
About ForHealth:
Founded in 1998, ForHealth Technologies delivers 21st century technology
combined with professional support to uniquely enable hospital pharmacies
to stay ahead of the growing challenges faced in preparing injectable
medications. ForHealth Technologies solutions deliver quantum-leap
improvements in key I.V. room performance metrics: accuracy, patient
safety, clinician safety, speed, cost reduction, and regulatory compliance.
ForHealth Technologies: Innovating for Your I.V. Room's Future™
Contact Information: For additional information, please contact: ForHealth Technologies Inc. Nicolas Boillot Hart-Boillot 781-893-0053 ForHealth Technologies Inc. Katie Delach Hart-Boillot 781-893-0053